Correction: mTORC1/S6K1 signaling promotes sustained oncogenic translation through modulating CRL3<sup>IBTK</sup>-mediated ubiquitination of eIF4A1 in cancer cells

Clinical OMICsGLP-1 Drugs Reduce Crime-Linked Behavior

Clinical OMICsMacrophage EGFR Activity Linked to Immune Suppression, Tumor Growth in Colorectal Cancer

Clinical OMICsUnexpected Role for RNA Editing in Cancer Immune Evasion Uncovered

Clinical OMICsProactive Surveillance Pays Off for Patients with Li-Fraumeni Syndrome

Clinical OMICsCAR T Success Hinges on Microenvironment Response in GBM

Endpoints NewsFDA warns telehealth companies over compounded GLP-1s

BioPharma DiveUniQure to file gene therapy for approval, reflecting major shifts at FDA

BioWorldEdgewise heads to phase III with solid EDG-7500 data in HCM

Endpoints NewsUK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says

Endpoints NewsHackers claim they stole Novo Nordisk AI models, manufacturing recipes

Endpoints NewsIn second reversal, FDA gives uniQure a green light to seek accelerated approval

BioPharma DiveJazz zeroes in on next-gen T cell engagers with AbCellera deal